421 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
GSK GlaxoSmithKline PLC $35.06 $86.22B Downtrend
Theravance Shares Rise on Approval of Glaxo's COPD Therapy http://www.zacks.com/stock/news/283321/theravance-shares-rise-on-approval-of-glaxos-copd-therapy?cid=CS-ZC-FT-283321 Nov 17, 2017 - Theravance Biopharma's (TBPH) shares traded up as investors cheered the potential cash flows related to future sales of recently approved Glaxo's triple combination COPD therapy.
Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study https://seekingalpha.com/article/4125900-daily-pharma-scoop-gilead-car-t-potential-egalet-surges-aerie-launches-mid-stage-study?source=feed_sector_healthcare Nov 17, 2017 - Gilead has adopted the right strategy in CAR-T. Egalet soars almost 40%. Aerie launches mid-stage study.
Glaxo's Triple Therapy COPD Inhaler Gets Marketing Nod in EU http://www.zacks.com/stock/news/283315/glaxos-triple-therapy-copd-inhaler-gets-marketing-nod-in-eu?cid=CS-ZC-FT-283315 Nov 17, 2017 - Glaxo (GSK) and partner Innoviva announced that their triple combination therapy, Trelegy Ellipta, was granted marketing authorization in the EU as maintenance therapy for the treatment of patients with COPD.
GSK IMPACT Award Winners bank $400K http://feeds.bizjournals.com/~r/industry_6/~3/An-NUKIwyWk/gsk-impact-award-winners-bank-400k.html Nov 16, 2017 - The annual GlaxoSmithKline IMPACT Awards have seen another set of 10 local nonprofits bank $40,000 each for their contributions to health in the Triangle.  “Health is about so much more than what happens in the doctor’s office,” stated Jamey Millar, senior vice president of GSK's Managed Markets & Government Affairs. “All of the community issues that our GSK IMPACT Award Winners address have a meaningful impact on health outcomes for individuals and families in the Triangle.” Studies…
Wall Street Breakfast: Order War At The Dubai Airshow https://seekingalpha.com/article/4125047-wall-street-breakfast-order-war-dubai-airshow?source=feed Nov 15, 2017 - Airbus has scored the biggest deal in its history, negotiating to sell 430 A320neos - valued at nearly $50B - to investment fund Indigo Partners. The pact gives Airbus (OTCPK:EADSY) the upper hand at
AstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA http://www.zacks.com/stock/news/282963/astrazenecas-azn-asthma-drug-benralizumab-approved-by-fda?cid=CS-ZC-FT-282963 Nov 15, 2017 - AstraZeneca (AZN) received FDA approval for benralizumab for treating severe eosinophilic asthma.
Glaxo And Pfizer Are Top 'Safer' Dividend Healthcare Gainers For November https://seekingalpha.com/article/4124932-glaxo-pfizer-top-safer-dividend-healthcare-gainers-november?source=feed_all_articles Nov 14, 2017 - GSK, the top safer dividend healthcare stock, with a 32.1% net gain was 3x Pfizer's 10.4% second-place effort, and 10x JNJ's eighth-place gains as per analyst targets.21 of 77 healthcare sector stocks
Kahn Brothers Reduces Positions in Straight Path, New York Times, Hologic, Several Others http://www.gurufocus.com/news/595610/kahn-brothers-reduces-positions-in-straight-path-new-york-times-hologic-several-others Nov 14, 2017 - Kahn Brothers Reduces Positions in Straight Path, New York Times, Hologic, Several Others, Stocks: STRP,NYT,HOLX,SEB,C,GSK,MBI, Kahn Brothers, release date:Nov 14, 2017
Healthcare Dogfight: GlaxoSmithKline Regains Top By Gains In November As O&M & Patterson Close-In https://seekingalpha.com/article/4124800-healthcare-dogfight-glaxosmithkline-regains-top-gains-november-o-and-m-and-patterson-close?source=feed_all_articles Nov 14, 2017 - GSK regained top dog by net gains, while TEVJF led again by yield as calculated 11/13/17.The Healthcare sector is composed of ten component industries. The top 50 firms selected by yield for this writ
Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge https://seekingalpha.com/article/4124669-daily-pharma-scoop-heron-undervalued-theravance-submits-nda-nektar-continues-surge?source=feed_sector_healthcare Nov 14, 2017 - Heron Therapeutics now has two approved products.Theravance has submitted revefenacin NDA.Nektar shares have gained more than 50% since last week.

Pages: 123456...43

Page 1>

Related Companies

Name Exchange Price Mkt Cap
AZN Astrazeneca PLC NYSE $33.46 $84.72B
CELG Celgene Corporation NASDAQ $104.1 $81.96B
LLY Eli Lilly and Company NYSE $82.89 $91.27B
ABT Abbott Laboratories NYSE $55.56 $96.71B
BMY Bristol-Myers Squibb Company NYSE $61.32 $100.36B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for GlaxoSmithKline PLC
GSK - Google Finance https://www.google.com/finance?q=GSK Industry related info and international coverage Summary News
GSK - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GSK Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options